South & Central America Nerve Repair & Regeneration Market Forecast to 2028 - COVID-19 Impact and Regional Analysis

Description

List of Tables

The nerve repair & regeneration market in South & Central America is expected to grow from US$ 343.17 million in 2022 to US$ 583.16 million by 2028; it is estimated to grow at a CAGR of 9.2% from 2022 to 2028.

Advancements in Stem Cell Therapy for Nerve Repair & Regeneration to Bolster Nerve Repair & Regeneration Market Growth in South & Central America during Forecast Period

Cell-based therapy improves the functional clinical outcome after nerve injury. In recent years, the technology in constructing tissue-engineered nerve grafts has seen significant progress. Incorporating stem cells such as embryonic stem cells, neural stem cells, bone marrow mesenchymal stem cells, adipose stem cells, skin-derived precursor stem cells, and induced pluripotent stem cells have enhanced the therapeutic effects of tissue-engineered nerve grafts. The high effectiveness of stem cells enlightens the optimistic future of the large-scale clinical use of stem cells. Incorporating stem cells as seed cells into the biomaterial-based scaffolds increases the effectiveness of tissue-engineered nerve grafts and boosts the regenerative process. Numerous stem cells such as neural stem cells, embryonic stem cells, adipose stem cells, skin-derived precursor stem cells, induced pluripotent stem cells, and bone marrow mesenchymal stem cells have been used in neural tissue engineering. Cell-based therapy improves neural regeneration after peripheral nerve injuries (PNIs); it has introduced a new perspective to regenerative medicine. The main mechanisms that highlight the valuable effects of stem cells on neural regeneration are augmenting axonal regeneration, remyelination, and muscle mass preservation. Thus, the advancements in stem cell therapy for nerve repair & regeneration are likely to offer growth opportunities for the nerve repair & regeneration market players operating in South & Central America.

Market Overview

The South & Central America nerve repair & regeneration market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil accounted for a significant share of the market in 2021, followed by Argentina. The nerve repair & regeneration market in South & Central America is expected to grow due to the rising cases of Parkinson's and Alzheimer's diseases, a surge in the geriatric population, and a rising number of developments by various organizations in countries across the region.

South & Central America Nerve Repair & Regeneration Market Revenue and Forecast to 2028 (US$ Million)

South & Central America Nerve Repair & Regeneration Market Segmentation

The South & Central America nerve repair & regeneration market is bifurcated on the basis of product and application.

Based on product, the South & Central America nerve repair & regeneration market is segmented into neurostimulation and neuromodulation devices and biomaterials. The neurostimulation and neuromodulation devices segment accounted for a larger market share in 2022. Based on application, the South & Central America nerve repair & regeneration market is bifurcated into neurostimulation & neuromodulation applications and nerve repair & regeneration applications. The nerve repair & regeneration applications segment held a larger market share in 2022. Based on country, the South & Central America nerve repair & regeneration market is segmented into Brazil, Argentina, and the Rest of South & Central America. Further, Brazil dominated the market in 2022. Axogen Corporation, Boston Scientific Corporation, Integra LifeSciences, Medtronic, Abbott Laboratories, Stryker Corporation, Neuronetics, LivaNova PLC, Baxter, and Polyganics BV are the leading companies operating in the nerve repair & regeneration market in South & Central America.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South & Central America nerve repair & regeneration market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the South & Central America nerve repair & regeneration market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the nerve repair & regeneration market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Product Code: BMIRE00027559

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 South & Central America Nerve Repair & Regeneration Market - By Product
  - 1.3.1.1 Neurostimulation and Neuromodulation Devices
  - 1.3.1.2 Biomaterials
- 1.3.2 South & Central America Nerve Repair & Regeneration Market - By Application
  - 1.3.2.1 Neurostimulation & Neuromodulation Applications
  - 1.3.2.2 Nerve Repair & Regeneration Applications
- 1.3.3 South & Central America Nerve Repair & Regeneration Market - By Country

2. South & Central America Nerve Repair & Regeneration Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. South & Central America Nerve Repair & Regeneration Market Landscape

4.1 Overview
4.2 PEST Analysis
4.3 Experts Opinion

5. South & Central America Nerve Repair & Regeneration Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Rising incidence of nerve injuries and high prevalence of neurological disorders
- 5.1.2 Surging Funding by Private and Government Organizations for Research in Neurology
5.2 Key Market Restraints
- 5.2.1 Dearth of trained professionals
5.3 Key Market Opportunities
- 5.3.1 Advances in Stem Cell Therapy in Nerve Repair & Regeneration
5.4 Future Trend
- 5.4.1 Increase In R&D Activities and Investment by Market Players
5.5 Impact analysis

6. South & Central America Nerve Repair & Regeneration Market Analysis

6.1 South & Central America Nerve Repair & Regeneration Market Revenue Forecast and Analysis

7. South & Central America Nerve Repair & Regeneration Market - by Product

7.1 Overview
7.2 By Product: Market Revenue and Forecast Analysis (US$ Million)
- 7.2.1 Neurostimulation and Neuromodulation Devices
  - 7.2.1.1 Overview
  - 7.2.1.2 Neurostimulation and Neuromodulation Devices Market Revenue and Forecast to 2028 (US$ Million)
  - 7.2.1.3 Internal Neurostimulation Devices
    - 7.2.1.3.1 Overview
    - 7.2.1.3.2 Internal Neurostimulation Devices Market Revenue and Forecast to 2028 (US$ Million)
    - 7.2.1.3.3 Spinal Cord Stimulation
    - 7.2.1.3.3.1 Overview
    - 7.2.1.3.3.2 Spinal Cord Stimulation Market Revenue and Forecast to 2028 (US$ Million)
    - 7.2.1.3.4 Deep Brain Stimulation
    - 7.2.1.3.4.1 Overview
    - 7.2.1.3.4.2 Deep Brain Stimulation Market Revenue and Forecast to 2028 (US$ Million)
    - 7.2.1.3.5 Vagus Nerve Stimulation
    - 7.2.1.3.5.1 Overview
    - 7.2.1.3.5.2 Vagus Nerve Stimulation Market Revenue and Forecast to 2028 (US$ Million)
    - 7.2.1.3.6 Sacral Nerve Stimulation
    - 7.2.1.3.6.1 Overview
    - 7.2.1.3.6.2 Sacral Nerve Stimulation Market Revenue and Forecast to 2028 (US$ Million)
    - 7.2.1.3.7 Gastric Electrical Stimulation
    - 7.2.1.3.7.1 Overview
    - 7.2.1.3.7.2 Gastric Electrical Stimulation Market Revenue and Forecast to 2028 (US$ Million)
  - 7.2.1.4 External Neurostimulation Devices
    - 7.2.1.4.1 Overview
    - 7.2.1.4.2 External Neurostimulation Devices Market Revenue and Forecast to 2028 (US$ Million)
    - 7.2.1.4.3 Transcutaneous Electrical Nerve Stimulation Devices
    - 7.2.1.4.3.1 Overview
    - 7.2.1.4.3.2 Transcutaneous Electrical Nerve Stimulation Devices Market Revenue and Forecast to 2028 (US$ Million)
    - 7.2.1.4.4 Transcranial Magnetic Stimulation Devices
    - 7.2.1.4.4.1 Overview
    - 7.2.1.4.4.2 Transcranial Magnetic Stimulation Devices Market Revenue and Forecast to 2028 (US$ Million)
    - 7.2.1.4.5 Respiratory Electrical Stimulation Devices
    - 7.2.1.4.5.1 Overview
    - 7.2.1.4.5.2 Respiratory Electrical Stimulation Devices Market Revenue and Forecast to 2028 (US$ Million)
- 7.2.2 Biomaterials
  - 7.2.2.1 Overview
  - 7.2.2.2 Biomaterials Market Revenue and Forecast to 2028 (US$ Million)
  - 7.2.2.3 Nerve conduits
    - 7.2.2.3.1 Overview
    - 7.2.2.3.2 Nerve conduits Market Revenue and Forecast to 2028 (US$ Million)
  - 7.2.2.4 Nerve wraps
    - 7.2.2.4.1 Overview
    - 7.2.2.4.2 Nerve wraps Market Revenue and Forecast to 2028 (US$ Million)
  - 7.2.2.5 Nerve Connectors
    - 7.2.2.5.1 Overview
    - 7.2.2.5.2 Nerve Connectors Market Revenue and Forecast to 2028 (US$ Million)
  - 7.2.2.6 Other Biomaterials
    - 7.2.2.6.1 Overview
    - 7.2.2.6.2 Other Biomaterials Market Revenue and Forecast to 2028 (US$ Million)

8. South & Central America Nerve Repair & Regeneration Market - by Application

8.1 Overview
8.2 By Application: Market Revenue and Forecast Analysis (US$ Million)
- 8.2.1 Neurostimulation & Neuromodulation applications
  - 8.2.1.1 Overview
  - 8.2.1.2 Neurostimulation & Neuromodulation applications Market Revenue and Forecast to 2028 (US$ Million)
  - 8.2.1.3 Internal neurostimulation and neuromodulation
    - 8.2.1.3.1 Overview
    - 8.2.1.3.2 Internal neurostimulation and neuromodulation Market Revenue and Forecast to 2028 (US$ Million)
  - 8.2.1.4 External neurostimulation and neuromodulation (LBL)
    - 8.2.1.4.1 Overview
    - 8.2.1.4.2 External neurostimulation and neuromodulation Market Revenue and Forecast to 2028 (US$ Million)
- 8.2.2 Nerve Repair & Regeneration Applications
  - 8.2.2.1 Overview
  - 8.2.2.2 Nerve Repair & Regeneration Applications Market Revenue and Forecast to 2028 (US$ Million)
  - 8.2.2.3 Direct Nerve Repair/Neurorrhaphy
    - 8.2.2.3.1 Overview
    - 8.2.2.3.2 Direct Nerve Repair/Neurorrhaphy Market Revenue and Forecast to 2028 (US$ Million)
    - 8.2.2.3.3 Epineural Repair
    - 8.2.2.3.3.1 Overview
    - 8.2.2.3.3.2 Epineural Repair Market Revenue and Forecast to 2028 (US$ Million)
    - 8.2.2.3.4 Perineural Repair
    - 8.2.2.3.4.1 Overview
    - 8.2.2.3.4.2 Perineural Repair Market Revenue and Forecast to 2028 (US$ Million)
    - 8.2.2.3.5 Group Fascicular Repair
    - 8.2.2.3.5.1 Overview
    - 8.2.2.3.5.2 Group Fascicular Repair Market Revenue and Forecast to 2028 (US$ Million)
  - 8.2.2.4 Nerve Grafting
    - 8.2.2.4.1 Overview
    - 8.2.2.4.2 Nerve Grafting Market Revenue and Forecast to 2028 (US$ Million)
    - 8.2.2.4.3 Autografts
    - 8.2.2.4.3.1 Overview
    - 8.2.2.4.3.2 Autografts Market Revenue and Forecast to 2028 (US$ Million)
    - 8.2.2.4.4 Allografts
    - 8.2.2.4.4.1 Overview
    - 8.2.2.4.4.2 Allografts Market Revenue and Forecast to 2028 (US$ Million)
    - 8.2.2.4.5 Xenografts
    - 8.2.2.4.5.1 Overview
    - 8.2.2.4.5.2 Xenografts Market Revenue and Forecast to 2028 (US$ Million)
  - 8.2.2.5 Stem cell therapy
    - 8.2.2.5.1 Overview
    - 8.2.2.5.2 Stem cell therapy Market Revenue and Forecast to 2028 (US$ Million)

9. South & Central America Nerve Repair & Regeneration Market - Country Analysis

9.1 Overview
- 9.1.1 South & Central America: Nerve Repair & Regeneration Market Revenue and Forecasts to 2028, By Country, 2021 & 2028 (%)
  - 9.1.1.1 Brazil: Nerve Repair & Regeneration Market Revenue and Forecasts to 2028 (US$ Million)
    - 9.1.1.1.1 Overview
    - 9.1.1.1.2 Brazil: Nerve Repair & Regeneration Market Revenue and Forecasts to 2028 (US$ Million)
    - 9.1.1.1.3 Brazil: Nerve Repair & Regeneration Market, By Product - 2019-2028 (US$ Million)
    - 9.1.1.1.3.1 Brazil: Nerve Repair & Regeneration Market, by Neurostimulation and Neuromodulation Devices - 2019-2028 (US$ Million)
    - 9.1.1.1.3.2 Brazil: Nerve Repair & Regeneration Market, By Biomaterials- 2019-2028 (US$ Million)
    - 9.1.1.1.4 Brazil: Nerve Repair & Regeneration Market, by Applications - 2019-2028 (US$ Million)
    - 9.1.1.1.4.1 Brazil: Nerve Repair & Regeneration Market, By Neurostimulation & Neuromodulation Applications- 2019-2028 (US$ Million)
    - 9.1.1.1.4.2 Brazil: Nerve Repair & Regeneration Market, by Nerve Repair & Regeneration Applications - 2019-2028 (US$ Million)
  - 9.1.1.2 Argentina: Nerve Repair & Regeneration Market Revenue and Forecasts to 2028 (US$ Million)
    - 9.1.1.2.1 Overview
    - 9.1.1.2.2 Argentina: Nerve Repair & Regeneration Market Revenue and Forecasts to 2028 (US$ Million)
    - 9.1.1.2.3 Argentina: Nerve Repair & Regeneration Market, By Product - 2019-2028 (US$ Million)
    - 9.1.1.2.3.1 Argentina: Nerve Repair & Regeneration Market, by Neurostimulation and Neuromodulation Devices - 2019-2028 (US$ Million)
    - 9.1.1.2.3.2 Argentina: Nerve Repair & Regeneration Market, By Biomaterials- 2019-2028 (US$ Million)
    - 9.1.1.2.4 Argentina: Nerve Repair & Regeneration Market, by Applications - 2019-2028 (US$ Million)
    - 9.1.1.2.4.1 Argentina: Nerve Repair & Regeneration Market, By Neurostimulation & Neuromodulation Applications- 2019-2028 (US$ Million)
    - 9.1.1.2.4.2 Argentina: Nerve Repair & Regeneration Market, by Nerve Repair & Regeneration Applications - 2019-2028 (US$ Million)
  - 9.1.1.3 Rest of South & Central America Nerve Repair & Regeneration Market Revenue and Forecasts to 2028 (US$ Million)
    - 9.1.1.3.1 Overview
    - 9.1.1.3.2 Rest of South & Central America: Nerve Repair & Regeneration Market Revenue and Forecasts to 2028 (US$ Million)
    - 9.1.1.3.3 Rest of South & Central America: Nerve Repair & Regeneration Market, By Product - 2019-2028 (US$ Million)
    - 9.1.1.3.3.1 Rest of South & Central America: Nerve Repair & Regeneration Market, by Neurostimulation and Neuromodulation Devices - 2019-2028 (US$ Million)
    - 9.1.1.3.3.2 Rest of South & Central America: Nerve Repair & Regeneration Market, By Biomaterials- 2019-2028 (US$ Million)
    - 9.1.1.3.4 Rest of South & Central America: Nerve Repair & Regeneration Market, by Applications - 2019-2028 (US$ Million)
    - 9.1.1.3.4.1 Rest of South & Central America: Nerve Repair & Regeneration Market, By Neurostimulation & Neuromodulation Applications- 2019-2028 (US$ Million)
    - 9.1.1.3.4.2 Rest of South & Central America: Nerve Repair & Regeneration Market, by Nerve Repair & Regeneration Applications - 2019-2028 (US$ Million)

10. South & Central America Nerve Repair & Regeneration Market - Industry Landscape

10.1 Overview
10.2 Inorganic Growth Strategies
- 10.2.1 Overview
10.3 Organic Growth Strategies
- 10.3.1 Overview

11. Company Profiles

11.1 Axogen Corporation
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Boston Scientific Corporation
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 Integra LifeSciences
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 Medtronic
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 Abbott Laboratories
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 Stryker Corporation
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 Neuronetics
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
11.8 LivaNova PLC
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments
11.9 Baxter
- 11.9.1 Key Facts
- 11.9.2 Business Description
- 11.9.3 Products and Services
- 11.9.4 Financial Overview
- 11.9.5 SWOT Analysis
- 11.9.6 Key Developments
11.10 Polyganics BV
- 11.10.1 Key Facts
- 11.10.2 Business Description
- 11.10.3 Products and Services
- 11.10.4 Financial Overview
- 11.10.5 SWOT Analysis
- 11.10.6 Key Developments

12. Appendix

12.1 About The Insight Partners
12.2 Glossary of Terms